The global nucleic acid isolation and purification market size was exhibited at USD 6.34 billion in 2022 and is projected to hit around USD 18.83 billion by 2032, growing at a CAGR of 11.5% during the forecast period 2023 to 2032.
Key Pointers:
Nucleic Acid Isolation And Purification Market Report Scope
Report Coverage | Details |
Market Size in 2023 | USD 7.07 Billion |
Market Size by 2032 | USD 18.83 Billion |
Growth Rate from 2023 to 2032 | CAGR of 11.5% |
Base year | 2022 |
Forecast period | 2023 to 2032 |
Segments covered | Product, Type, Method, Application, End-use |
Regional scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
Key companies profiled | QIAGEN; Thermo Fisher Scientific, Inc.; Illumina, Inc.; Danaher; F. Hoffmann-La Roche AG; Merck KGaA; Agilent Technologies; Bio-Rad Laboratories, Inc.; Takara Bio, Inc.; Promega Corporation; New England Biolabs; LGC Limited; Abcam plc; Norgen Biotek Corp; AutoGen, Inc.; Biogenuix; PCR Biosystems, Inc.; MagGenome; Apical Scientific Sdn. Bhd; MACHEREY-NAGEL GmbH & Co. KG |
Key drivers contributing to the market growth are the rise in adoption of sequencing platforms in clinical diagnostics, growth in genomics and enzymology-based research, and increasing investments in R&D pertaining to molecular biology and precision medicine.
The growing collaborations between different companies and organizations in the biotech industry is one of the factors driving the market. For instance, in March 2022, Zymo Research and Tecan partnered to introduce ready-to-use processing products that can streamline DNA or RNA extraction from COVID-19 specimens. The new DreamPrep NAP workstation assists laboratories to effectively and rapidly scale lab testing to provide a larger number of tests, consequently helping in mitigating the spread of the virus.
The development of personalized medicine is another important factor that drives revenue generation in the market for nucleic acid isolation and purification. Next Generation Sequencing (NGS) is becoming increasingly popular in cancer tumor biopsies. Liquid biopsies are an attractive option for cancer diagnostics because the process employs a simple and routine test that can detect cancer at an early stage.
Early diagnosis of cancer is the biggest challenge, and NGS can help effectively tackle the problem, increasing the demand for NGS technology. Therefore, an increase in the use of NGS technology is anticipated to directly impact the adoption of nucleic acid isolation and purification techniques.
Formalin-Fixed Paraffin-Embedded (FFPE) samples that are considered important in determining molecular correlates of carcinogenesis require labor-intensive nucleic acid purification for the sample, and such protocols also damage the nucleic acids. To combat such challenges companies are launching new extraction kits for efficient recovery of nucleic acids.
For instance, in March 2022, Purigen Biosystems, Inc. launched the Ionic FFPE Complete Purification Kit for recovering RNA/DNA from FFPE tissue samples in a single workflow. It helps in streamlining the workflow by reducing hands-on time by around 78% when compared to the manual column or bead-based methods. Hence, such advancements are further boosting the market growth.
Furthermore, the COVID-19 pandemic is acting as a positive catalyst for the growth of the market for nucleic acid isolation and purification. Researchers and companies across the world are focusing on developing specific assays and kits for rapid detection of SARS-CoV-2. For instance, in June 2020, Omega Bio-tek, Inc. launched Mag-Bind Viral RNA Xpress Kit for efficient and rapid isolation of viral RNA. In addition, the company also announced to have a production capacity of 6 million tests per month which brought a dramatic increase in the production capacities.
Some of the prominent players in the Nucleic Acid Isolation And Purification Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Nucleic Acid Isolation And Purification market.
By Product
By Type
By Method
By Application
By End-use
By Region
Chapter 1 Methodology and Scope
1.1 Research Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Nova one advisor’s Internal Database
1.3.3 Secondary Sources
1.3.3.1 List of secondary data sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Primary Interviews: Statistics
1.3.5.1.1 Geographical distribution of primary interviews
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Parent & ancillary techniques
1.7 Product Scope
1.7.1 Definition
1.7.1.1 Instruments
1.7.1.2 Kits & reagents
1.7.2 Market model
1.8 Type Scope
1.8.1 Definition
1.8.1.1 DNA isolation & purification
1.8.1.2 RNA isolation & purification
1.8.2 Market model
1.9 Method Scope
1.9.1 Definition
1.9.1.1 Column based
1.9.1.2 Magnetic bead based
1.9.1.3 Reagent based
1.9.1.4 Others
1.9.2 Market model
1.9.2.1 By method
1.10 Application Scope
1.10.1 Definition
1.10.1.1 Precision medicine
1.10.1.2 Diagnostics
1.10.1.3 Drug Discovery & Development
1.10.1.4 Agriculture and Animal Research
1.10.1.5 Other Applications
1.10.2 Market model
1.11 End-use Scope
1.11.1 Definition
1.11.1.1 Academic research institutes
1.11.1.2 Pharmaceutical & biotechnology companies
1.11.1.3 Contract research organizations
1.11.1.4 Hospitals and diagnostic centers
1.11.1.5 Other End-use
1.11.2 Market model
1.12 Regional Scope
1.12.1 Region-wise market: Base estimates
1.13 Objectives
1.13.1 Objective 1:
1.13.2 Objective 2:
Chapter 2 Executive Summary
2.1 Nucleic Acid Isolation And Purification Market: Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent & ancillary market outlook
3.2 Nucleic Acid Isolation & Purification Market: Technology Trends
3.2.1 Technology trends
3.3 Outsourcing & contract manufacturing trends
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Increasing incidence of cancer, genetic disorders, and infectious diseases
3.4.1.2 Increase in public-private funding on biotechnology and life sciences research
3.4.1.3 Advancements in automation
3.4.1.4 Growth in NGS technologies
3.4.1.5 Growing demand for genetically modified crops and organisms
3.4.2 Market restraint analysis
3.4.2.1 Expensive instruments and consequent low penetration in emerging countries
3.4.2.2 Challenges related to the use of big data and bioinformatics
3.4.3 Market opportunity analysis
3.4.3.1 Automation in nucleic acid isolation and purification techniques
3.4.3.2 Adoption of downstream applications of nucleic acid purification and isolation for COVID-19 diagnostics
3.4.4 Market challenge analysis
3.4.4.1 Challenges associated with sample preparation
3.5 Penetration & Growth Prospect Mapping for Method, 2020
3.6 COVID-19 Impact Analysis on Market
3.6.1 Utilization of nucleic acid isolation and purification kits for analysis of COVID-19 samples
3.6.2 Shortage of RNA isolation kits
3.6.3 Increase in global production capacities
3.7 BUSINESS ENVIRONMENT ANALYSIS
3.7.1 Nucleic Acid Isolation & Purification Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.7.2 Porter’s Five Forces Analysis
3.8 Major Deals & Strategic Alliances Analysis
3.8.1 Product developments
3.8.2 Merger & acquisition
3.8.3 Agreement
3.8.4 Collaboration & partnership
Chapter 4 Product Business Analysis
4.1 Nucleic Acid Isolation and Purification Market: Product Movement Analysis
4.2 Kits & Reagents
4.2.1 Kits & reagents market estimates and forecasts, 2020 - 2032
4.3 Instruments
4.3.1 Instruments market estimates and forecasts, 2020 - 2032
Chapter 5 Type Business Analysis
5.1 Nucleic Acid Isolation and Purification Market: Type Movement Analysis
5.2 DNA Isolation & Purification
5.2.1 DNA isolation & purification market estimates and forecasts, 2020 - 2032
5.2.2 Genomic DNA isolation & purification
5.2.2.1 Genomic DNA isolation & purification market estimates and forecasts, 2020 - 2032
5.2.3 Plasmid DNA isolation & purification
5.2.3.1 Plasmid DNA isolation & purification market estimates and forecasts, 2020 - 2032
5.2.4 Viral DNA isolation & purification
5.2.4.1 Viral DNA isolation & purification market estimates and forecasts, 2020 - 2032
5.2.5 Other types
5.2.5.1 Others market estimates and forecasts, 2020 - 2032
5.3 RNA Isolation & Purification
5.3.1 RNA isolation & purification market estimates and forecasts, 2020 - 2032
5.3.2 RNA Isolation Reagents and Instruments Market, By End Use
5.3.2.1 Manufacturing/bioprocessing
5.3.2.2 Research
5.3.2.3 Clinical/diagnostics
5.3.3 miRNA isolation and purification
5.3.3.1 miRNA isolation & purification market estimates and forecasts, 2020 - 2032
5.3.4 mRNA isolation & purification
5.3.4.1 mRNA isolation & purification market estimates and forecasts, 2020 - 2032
5.3.5 Total RNA isolation & purification
5.3.5.1 Total RNA isolation & purification market estimates and forecasts, 2020 - 2032
5.3.6 Other types
5.3.6.1 Others market estimates and forecasts, 2020 - 2032
Chapter 6 Method Business Analysis
6.1 Nucleic Acid Isolation and Purification Market: Method Movement Analysis
6.2 Column Based Isolation & Purification
6.2.1 Column based market estimates and forecasts, 2020 - 2032
6.3 Magnetic Bead Based Isolation & Purification
6.3.1 Magnetic beads market estimates and forecasts, 2020 - 2032
6.4 Reagent Based Isolation & Purification
6.4.1 Reagent based market estimates and forecasts, 2020 - 2032
6.5 Other Methods
6.5.1 Others market estimates and forecasts, 2020 - 2032
Chapter 7 Application Business Analysis
7.1 Nucleic Acid Isolation and Purification Market: Application Movement Analysis
7.2 Precision Medicine
7.2.1 Precision medicine market estimates and forecasts, 2020 - 2032
7.3 Diagnostics
7.3.1 Diagnostics market estimates and forecasts, 2020 - 2032
7.4 Drug Discovery & Development
7.4.1 Drug discovery & development market estimates and forecasts, 2020 - 2032
7.5 Agriculture & Animal Research
7.5.1 Agriculture and animal research market estimates and forecasts, 2020 - 2032
7.6 Other Applications
7.6.1 Other applications market estimates and forecasts, 2020 - 2032
Chapter 8 End-use Business Analysis
8.1 Nucleic Acid Isolation and Purification Market: End-use Movement Analysis
8.1.1 Application Scope: Test Type Penetration
8.2 Academic Research Institutes
8.2.1 Academic research institutes market estimates and forecasts, 2020 - 2032
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Pharmaceutical & biotechnology companies market estimates and forecasts, 2020 - 2032
8.4 Contract Research Organizations
8.4.1 Contract Research Organizations market estimates and forecasts, 2020 - 2032
8.5 Hospitals and Diagnostic Centers
8.5.1 Hospitals and diagnostic centers market estimates and forecasts, 2020 - 2032
8.6 Other End-use
8.6.1 Other end-use market estimates and forecasts, 2020 - 2032
Chapter 9 Regional Business Analysis
9.1 Nucleic Acid Isolation & Purification Market Share By Region, 2020 & 2032
9.2 North America
9.2.1 North America market estimates and forecasts, 2020 - 2032
9.2.2 U.S.
9.2.2.1 U.S. nucleic acid isolation & purification market, by product, 2020 - 2032
9.2.2.2 U.S. nucleic acid isolation & purification market, by type, 2020 - 2032
9.2.2.3 U.S. nucleic acid isolation & purification market, by method, 2020 - 2032
9.2.2.4 U.S. nucleic acid isolation & purification market, by application, 2020 - 2032
9.2.2.5 U.S. nucleic acid isolation & purification market, by end use, 2020 - 2032
9.2.3 Canada
9.2.3.1 Canada nucleic acid isolation & purification market, by product, 2020 - 2032
9.2.3.2 Canada nucleic acid isolation & purification market, by type, 2020 - 2032
9.2.3.3 Canada nucleic acid isolation & purification market, by method, 2020 - 2032
9.2.3.4 Canada nucleic acid isolation & purification market, by application, 2020 - 2032
9.2.3.5 Canada nucleic acid isolation & purification market, by end use, 2020 - 2032
9.3 Europe
9.3.1 Europe market estimates and forecasts, 2020 - 2032
9.3.2 Germany
9.3.2.1 Germany nucleic acid isolation & purification market, by product, 2020 - 2032
9.3.2.2 Germany nucleic acid isolation & purification market, by type, 2020 - 2032
9.3.2.3 Germany nucleic acid isolation & purification market, by method, 2020 - 2032
9.3.2.4 Germany nucleic acid isolation & purification market, by application, 2020 - 2032
9.3.2.5 Germany nucleic acid isolation & purification market, by end use, 2020 - 2032
9.3.3 U.K.
9.3.3.1 U.K. nucleic acid isolation & purification market, by product, 2020 - 2032
9.3.3.2 U.K. nucleic acid isolation & purification market, by type, 2020 - 2032
9.3.3.3 U.K. nucleic acid isolation & purification market, by method, 2020 - 2032
9.3.3.4 U.K. nucleic acid isolation & purification market, by application, 2020 - 2032
9.3.3.5 U.K. nucleic acid isolation & purification market, by end use, 2020 - 2032
9.4 Asia Pacific
9.4.1 Asia Pacific market estimates and forecasts, 2020 - 2032
9.4.2 Japan
9.4.2.1 Japan nucleic acid isolation & purification market, by product, 2020 - 2032
9.4.2.2 Japan nucleic acid isolation & purification market, by type, 2020 - 2032
9.4.2.3 Japan nucleic acid isolation & purification market, by method, 2020 - 2032
9.4.2.4 Japan nucleic acid isolation & purification market, by application, 2020 - 2032
9.4.2.5 Japan nucleic acid isolation & purification market, by end use, 2020 - 2032
9.4.3 China
9.4.3.1 China nucleic acid isolation & purification market, by product, 2020 - 2032
9.4.3.2 China nucleic acid isolation & purification market, by type, 2020 - 2032
9.4.3.3 China nucleic acid isolation & purification market, by method, 2020 - 2032
9.4.3.4 China nucleic acid isolation & purification market, by application, 2020 - 2032
9.4.3.5 China nucleic acid isolation & purification market, by end use, 2020 - 2032
9.5 Latin America
9.5.1 Latin America market estimates and forecasts, 2020 - 2032
9.5.2 Brazil
9.5.2.1 Brazil nucleic acid isolation & purification market, by product, 2020 - 2032
9.5.2.2 Brazil nucleic acid isolation & purification market, by type, 2020 - 2032
9.5.2.3 Brazil nucleic acid isolation & purification market, by method, 2020 - 2032
9.5.2.4 Brazil nucleic acid isolation & purification market, by application, 2020 - 2032
9.5.2.5 Brazil nucleic acid isolation & purification market, by end use, 2020 - 2032
9.5.3 Mexico
9.5.3.1 Mexico nucleic acid isolation & purification market, by product, 2020 - 2032
9.5.3.2 Mexico nucleic acid isolation & purification market, by type, 2020 - 2032
9.5.3.3 Mexico nucleic acid isolation & purification market, by method, 2020 - 2032
9.5.3.4 Mexico nucleic acid isolation & purification market, by application, 2020 - 2032
9.5.3.5 Mexico nucleic acid isolation & purification market, by end use, 2020 - 2032
9.6 Middle East and Africa (MEA)
9.6.1 MEA market estimates and forecasts, 2020 - 2032
9.6.2 South Africa
9.6.3.1 South Africa nucleic acid isolation & purification market, by product, 2020 - 2032
9.6.3.2 South Africa nucleic acid isolation & purification market, by type, 2020 - 2032
9.6.3.3 South Africa nucleic acid isolation & purification market, by method, 2020 - 2032
9.6.3.4 South Africa nucleic acid isolation & purification market, by application, 2020 - 2032
9.6.3.5 South Africa nucleic acid isolation & purification market, by end use, 2020 - 2032
Chapter 10 Competitive Landscape
10.1 Company categorization
10.2 Strategy framework
10.3 Competitive Landscape
10.4 Public Companies
10.4.1 Company size
10.4.2 Geographical presence
10.4.3 Product portfolio
10.4.4 Segment coverage
10.4.5 Other factors
10.5 Private Companies
10.5.1 List of key emerging companies
10.6 Company Profiles
10.6.1 QIAGEN
10.6.1.1 Company overview
10.6.1.2 Financial Performance
10.6.1.3 Product benchmarking
10.6.1.4 Strategic initiatives
10.6.2 Thermo Fisher Scientific, Inc.
10.6.2.1 Company overview
10.6.2.2 Financial Performance
10.6.2.3 Product benchmarking
10.6.2.4 Strategic initiatives
10.6.3 Illumina Inc
10.6.3.1 Company overview
10.6.3.1.1 Epicentre (An Illumina Company)
10.6.3.2 Financial performance
10.6.3.3 Product benchmarking
10.6.3.4 Strategic initiatives
10.6.4 Danaher Corporation
10.6.4.1 Company overview
10.6.4.1.1 Beckman Coulter, Inc.
10.6.4.1.2 Cytiva (formerly GE Healthcare)
10.6.4.2 Financial Performance
10.6.4.2.1 Financial Performance: Cytiva
10.6.4.3 Product benchmarking
10.6.4.4 Strategic initiatives
10.6.5 F. Hoffmann-La Roche Ltd.
10.6.5.1 Company overview
10.6.5.2 Financial Performance
10.6.5.3 Product benchmarking
10.6.5.4 Strategic initiatives
10.6.6 Merck KGaA
10.6.6.1 Company overview
10.6.6.1.1 Sigma-Aldrich Co. LLC
10.6.6.2 Financial Performance
10.6.6.3 Product benchmarking
10.6.6.4 Strategic initiatives
10.6.7 Agilent Technologies
10.6.7.1 Company overview
10.6.7.2 Financial Performance
10.6.7.3 Product benchmarking
10.6.7.4 Strategic initiatives
10.6.8 Bio-Rad Laboratories, Inc.
10.6.8.1 Company overview
10.6.8.2 Financial Performance
10.6.8.3 Product benchmarking
10.6.8.4 Strategic initiatives
10.6.9 TAKARA BIO, INC.
10.6.9.1 COMPANY OVERVIEW
10.6.9.1.1 Clontech Laboratories, Inc.
10.6.9.2 FINANCIAL PERFORMANCE
10.6.9.3 PRODUCT BENCHMARKING
10.6.9.4 STRATEGIC INITIATIVES
10.6.10 Promega Corporation
10.6.10.1 Company overview
10.6.10.2 Financial Performance
10.6.10.3 Product benchmarking
10.6.10.4 STRATEGIC INITIATIVES
10.6.11 New England Biolabs
10.6.11.1 Company overview
10.6.11.2 Financial Performance
10.6.11.3 Product benchmarking
10.6.11.4 Strategic initiatives
10.6.12 LGC Limited
10.6.12.1 Company overview
10.6.12.1.1 LGC Biosearch Technologies
10.6.12.2 Financial Performance
10.6.12.3 Product benchmarking
10.6.12.4 Strategic initiatives
10.6.13 Abcam plc
10.6.13.1 Company overview
10.6.13.2 Financial Performance
10.6.13.3 Product benchmarking
10.6.14 Norgen Biotek Corp.
10.6.14.1 Company overview
10.6.14.2 Product benchmarking
10.6.14.3 Strategic initiatives
10.6.15 AUTOGEN. INC.
10.6.15.1 Company overview
10.6.15.2 Financial Performance
10.6.15.3 Product benchmarking
10.6.15.4 Strategic initiatives
10.6.16 Biogenuix
10.6.16.1 Company overview
10.6.16.2 Product benchmarking
10.6.16.3 Strategic initiatives
10.6.17 PCR Biosystems, Inc.
10.6.17.1 Company overview
10.6.17.2 Financial Performance
10.6.17.3 Product benchmarking
10.6.17.4 Strategic initiatives
10.6.18 MagGenome
10.6.18.1 Company overview
10.6.18.2 Product benchmarking
10.6.18.3 Strategic initiatives
10.6.19 Axon Scientific Sdn. Bhd./ Apical Scientific Sdn. Bhd.
10.6.19.1 Company overview
10.6.19.2 Product benchmarking
10.6.20 MACHEREY-NAGEL GmbH & Co. KG
10.6.20.1 Company overview
10.6.20.2 Financial Performance
10.6.20.3 Product benchmarking
10.6.20.4 Strategic initiatives